Covaxin, Covishield get regular market nod, with some riders{br} https://ift.tt/eA8V8J

Drug regulator DCGI on Thursday granted regular marketing authorisation to the two commonly used Covid vaccines — Covishield and Covaxin — for use in adults with certain conditions. However, the vaccines will be available only under “programmatic setting” and all vaccinations have to be recorded on CoWIN.

from Times of India https://ift.tt/3KJlNHX